| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |